Effects of the 5-HT 2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of …

Abstract

Previously the NMDA (N-methyl-D-aspartate) receptor (NMDAR) antagonist ketamine was shown to disrupt generation of the auditory event-related potential (ERP) mismatch negativity (MMN) and the performance of an 'AX'-type continuous performance test (AX-CPT) …